

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.14077072 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.14077072 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.81252670 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.81252670 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.41942136 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 5.88680289 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 5.88680289 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.88680289 |
| 9 | bile acid biosynthetic process (GO:0006699) | 5.83405441 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.77019050 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.71674142 |
| 12 | high-density lipoprotein particle remodeling (GO:0034375) | 5.52139457 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.47762974 |
| 14 | alpha-linolenic acid metabolic process (GO:0036109) | 5.33764260 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.28280626 |
| 16 | urea cycle (GO:0000050) | 5.22414156 |
| 17 | urea metabolic process (GO:0019627) | 5.22414156 |
| 18 | regulation of protein activation cascade (GO:2000257) | 5.19797333 |
| 19 | complement activation, alternative pathway (GO:0006957) | 5.18300118 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.06365422 |
| 21 | protein carboxylation (GO:0018214) | 4.97374218 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.97374218 |
| 23 | regulation of fibrinolysis (GO:0051917) | 4.97289935 |
| 24 | bile acid metabolic process (GO:0008206) | 4.96303089 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 4.91770091 |
| 26 | cysteine metabolic process (GO:0006534) | 4.88823226 |
| 27 | regulation of complement activation (GO:0030449) | 4.87394194 |
| 28 | reverse cholesterol transport (GO:0043691) | 4.77649140 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 4.77117489 |
| 30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.66340748 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 4.63624926 |
| 32 | negative regulation of sterol transport (GO:0032372) | 4.62913700 |
| 33 | negative regulation of cholesterol transport (GO:0032375) | 4.62913700 |
| 34 | aromatic amino acid family metabolic process (GO:0009072) | 4.61782452 |
| 35 | behavioral response to nicotine (GO:0035095) | 4.61540830 |
| 36 | macromolecular complex remodeling (GO:0034367) | 4.57563067 |
| 37 | plasma lipoprotein particle remodeling (GO:0034369) | 4.57563067 |
| 38 | protein-lipid complex remodeling (GO:0034368) | 4.57563067 |
| 39 | coenzyme catabolic process (GO:0009109) | 4.45819333 |
| 40 | acylglycerol homeostasis (GO:0055090) | 4.42001877 |
| 41 | triglyceride homeostasis (GO:0070328) | 4.42001877 |
| 42 | regulation of cholesterol esterification (GO:0010872) | 4.37705737 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.33915929 |
| 44 | homocysteine metabolic process (GO:0050667) | 4.32722958 |
| 45 | alpha-amino acid catabolic process (GO:1901606) | 4.32206823 |
| 46 | cellular ketone body metabolic process (GO:0046950) | 4.28160751 |
| 47 | amino-acid betaine metabolic process (GO:0006577) | 4.25413251 |
| 48 | regulation of triglyceride catabolic process (GO:0010896) | 4.24384305 |
| 49 | lysine metabolic process (GO:0006553) | 4.23833159 |
| 50 | lysine catabolic process (GO:0006554) | 4.23833159 |
| 51 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.22846791 |
| 52 | bile acid and bile salt transport (GO:0015721) | 4.19344996 |
| 53 | cholesterol efflux (GO:0033344) | 4.18327687 |
| 54 | glutamate metabolic process (GO:0006536) | 4.14979244 |
| 55 | phospholipid efflux (GO:0033700) | 4.14326101 |
| 56 | indolalkylamine metabolic process (GO:0006586) | 4.12192756 |
| 57 | plasma lipoprotein particle clearance (GO:0034381) | 4.10042139 |
| 58 | response to pheromone (GO:0019236) | 4.08042601 |
| 59 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.06604644 |
| 60 | imidazole-containing compound metabolic process (GO:0052803) | 4.05132347 |
| 61 | cellular biogenic amine catabolic process (GO:0042402) | 3.97423278 |
| 62 | amine catabolic process (GO:0009310) | 3.97423278 |
| 63 | cellular amino acid catabolic process (GO:0009063) | 3.97114697 |
| 64 | regulation of bile acid biosynthetic process (GO:0070857) | 3.95107491 |
| 65 | cellular modified amino acid catabolic process (GO:0042219) | 3.84648964 |
| 66 | cellular glucuronidation (GO:0052695) | 3.81240934 |
| 67 | cytolysis (GO:0019835) | 3.80610924 |
| 68 | benzene-containing compound metabolic process (GO:0042537) | 3.80387256 |
| 69 | adaptation of signaling pathway (GO:0023058) | 3.80245654 |
| 70 | platelet dense granule organization (GO:0060155) | 3.79436374 |
| 71 | short-chain fatty acid metabolic process (GO:0046459) | 3.78413839 |
| 72 | drug catabolic process (GO:0042737) | 3.74314729 |
| 73 | regulation of cholesterol homeostasis (GO:2000188) | 3.72142963 |
| 74 | ketone body metabolic process (GO:1902224) | 3.69777876 |
| 75 | glycine metabolic process (GO:0006544) | 3.69477510 |
| 76 | complement activation, classical pathway (GO:0006958) | 3.69414606 |
| 77 | nucleobase catabolic process (GO:0046113) | 3.68417497 |
| 78 | arginine metabolic process (GO:0006525) | 3.63485531 |
| 79 | ethanol oxidation (GO:0006069) | 3.63119070 |
| 80 | negative regulation of lipase activity (GO:0060192) | 3.62525478 |
| 81 | fibrinolysis (GO:0042730) | 3.61563756 |
| 82 | serine family amino acid metabolic process (GO:0009069) | 3.60983071 |
| 83 | low-density lipoprotein particle remodeling (GO:0034374) | 3.60846598 |
| 84 | complement activation (GO:0006956) | 3.56064085 |
| 85 | plasma lipoprotein particle assembly (GO:0034377) | 3.56023271 |
| 86 | piRNA metabolic process (GO:0034587) | 3.55976980 |
| 87 | phospholipid homeostasis (GO:0055091) | 3.51730400 |
| 88 | protein activation cascade (GO:0072376) | 3.49934010 |
| 89 | blood coagulation, intrinsic pathway (GO:0007597) | 3.49090292 |
| 90 | cofactor catabolic process (GO:0051187) | 3.48516367 |
| 91 | organic acid catabolic process (GO:0016054) | 3.47337080 |
| 92 | carboxylic acid catabolic process (GO:0046395) | 3.47337080 |
| 93 | negative regulation of protein activation cascade (GO:2000258) | 3.45490779 |
| 94 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.44251539 |
| 95 | acetyl-CoA metabolic process (GO:0006084) | 3.43944259 |
| 96 | plasma lipoprotein particle organization (GO:0071827) | 3.40921920 |
| 97 | axoneme assembly (GO:0035082) | 3.40782847 |
| 98 | positive regulation of lipid catabolic process (GO:0050996) | 3.39943863 |
| 99 | opsonization (GO:0008228) | 3.37853256 |
| 100 | uronic acid metabolic process (GO:0006063) | 3.34705696 |
| 101 | glucuronate metabolic process (GO:0019585) | 3.34705696 |
| 102 | dopamine transport (GO:0015872) | 3.34441466 |
| 103 | cholesterol homeostasis (GO:0042632) | 3.34396872 |
| 104 | proline transport (GO:0015824) | 3.32450704 |
| 105 | aldehyde catabolic process (GO:0046185) | 3.30396215 |
| 106 | sterol homeostasis (GO:0055092) | 3.29264497 |
| 107 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.29127851 |
| 108 | aspartate family amino acid catabolic process (GO:0009068) | 3.28624327 |
| 109 | monocarboxylic acid catabolic process (GO:0072329) | 3.26376236 |
| 110 | fatty acid oxidation (GO:0019395) | 3.25864866 |
| 111 | protein complex biogenesis (GO:0070271) | 3.25188911 |
| 112 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.24123580 |
| 113 | NADH dehydrogenase complex assembly (GO:0010257) | 3.24123580 |
| 114 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.24123580 |
| 115 | presynaptic membrane assembly (GO:0097105) | 3.22918127 |
| 116 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.22068412 |
| 117 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.19055106 |
| 118 | regulation of gene silencing by miRNA (GO:0060964) | 3.19055106 |
| 119 | regulation of gene silencing by RNA (GO:0060966) | 3.19055106 |
| 120 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.16094336 |
| 121 | DNA methylation involved in gamete generation (GO:0043046) | 3.15106240 |
| 122 | acrosome reaction (GO:0007340) | 3.14056921 |
| 123 | DNA double-strand break processing (GO:0000729) | 3.13830682 |
| 124 | regulation of glucokinase activity (GO:0033131) | 3.11434036 |
| 125 | regulation of hexokinase activity (GO:1903299) | 3.11434036 |
| 126 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.10075842 |
| 127 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.10075737 |
| 128 | kidney morphogenesis (GO:0060993) | 3.07439780 |
| 129 | sperm motility (GO:0030317) | 3.06505858 |
| 130 | protein-cofactor linkage (GO:0018065) | 3.05333757 |
| 131 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.05249790 |
| 132 | detection of light stimulus involved in visual perception (GO:0050908) | 3.05249790 |
| 133 | protein polyglutamylation (GO:0018095) | 3.05218091 |
| 134 | gamma-aminobutyric acid transport (GO:0015812) | 3.03910428 |
| 135 | regulation of telomere maintenance (GO:0032204) | 3.03223752 |
| 136 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.99831589 |
| 137 | behavioral response to ethanol (GO:0048149) | 2.99016972 |
| 138 | protein localization to cilium (GO:0061512) | 2.98684094 |
| 139 | regulation of meiosis I (GO:0060631) | 2.96419944 |
| 140 | fucose catabolic process (GO:0019317) | 2.95598158 |
| 141 | L-fucose metabolic process (GO:0042354) | 2.95598158 |
| 142 | L-fucose catabolic process (GO:0042355) | 2.95598158 |
| 143 | regulation of action potential (GO:0098900) | 2.95249657 |
| 144 | somite rostral/caudal axis specification (GO:0032525) | 2.94382693 |
| 145 | organic cation transport (GO:0015695) | 2.90626523 |
| 146 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.86583166 |
| 147 | single strand break repair (GO:0000012) | 2.83989670 |
| 148 | epithelial cilium movement (GO:0003351) | 2.83897516 |
| 149 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.80381739 |
| 150 | multicellular organism reproduction (GO:0032504) | 2.80202244 |
| 151 | alanine transport (GO:0032328) | 2.79048712 |
| 152 | cilium morphogenesis (GO:0060271) | 2.78994611 |
| 153 | C4-dicarboxylate transport (GO:0015740) | 2.77476864 |
| 154 | reflex (GO:0060004) | 2.77466918 |
| 155 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.77463507 |
| 156 | positive regulation of meiosis (GO:0045836) | 2.77140643 |
| 157 | glycerophospholipid catabolic process (GO:0046475) | 2.75935005 |
| 158 | photoreceptor cell maintenance (GO:0045494) | 2.73953553 |
| 159 | presynaptic membrane organization (GO:0097090) | 2.72920628 |
| 160 | serotonin receptor signaling pathway (GO:0007210) | 2.72167997 |
| 161 | neural tube formation (GO:0001841) | 2.72154365 |
| 162 | respiratory chain complex IV assembly (GO:0008535) | 2.71033943 |
| 163 | centriole replication (GO:0007099) | 2.68000908 |
| 164 | atrial cardiac muscle cell action potential (GO:0086014) | 2.66272064 |
| 165 | protein K11-linked deubiquitination (GO:0035871) | 2.64536009 |
| 166 | rhodopsin mediated signaling pathway (GO:0016056) | 2.64252108 |
| 167 | calcium ion-dependent exocytosis (GO:0017156) | 2.63935689 |
| 168 | tachykinin receptor signaling pathway (GO:0007217) | 2.60332672 |
| 169 | transmission of nerve impulse (GO:0019226) | 2.57790366 |
| 170 | positive regulation of meiotic cell cycle (GO:0051446) | 2.57037945 |
| 171 | neuronal action potential (GO:0019228) | 2.53264486 |
| 172 | negative regulation of telomere maintenance (GO:0032205) | 2.51825614 |
| 173 | signal peptide processing (GO:0006465) | 2.49358671 |
| 174 | DNA deamination (GO:0045006) | 2.47772790 |
| 175 | reciprocal meiotic recombination (GO:0007131) | 2.46727291 |
| 176 | reciprocal DNA recombination (GO:0035825) | 2.46727291 |
| 177 | postsynaptic membrane organization (GO:0001941) | 2.46689456 |
| 178 | nonmotile primary cilium assembly (GO:0035058) | 2.44468824 |
| 179 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.43954349 |
| 180 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.43954349 |
| 181 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.43954349 |
| 182 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.43742147 |
| 183 | cilium movement (GO:0003341) | 2.41822561 |
| 184 | protein neddylation (GO:0045116) | 2.41483684 |
| 185 | anterograde synaptic vesicle transport (GO:0048490) | 2.40725788 |
| 186 | male meiosis I (GO:0007141) | 2.38910226 |
| 187 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.38716166 |
| 188 | arginine catabolic process (GO:0006527) | 2.38417420 |
| 189 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.37326322 |
| 190 | sulfation (GO:0051923) | 2.36766676 |
| 191 | cytochrome complex assembly (GO:0017004) | 2.35007367 |
| 192 | retinal cone cell development (GO:0046549) | 2.34878500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.85857012 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.01478016 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.84673048 |
| 4 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.55996104 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.47271722 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.55455354 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.75768995 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.73311918 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.55812959 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.54392371 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.07806524 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.03550429 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.79735316 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.35003500 |
| 15 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.27613297 |
| 16 | FUS_26573619_Chip-Seq_HEK293_Human | 2.09173730 |
| 17 | EWS_26573619_Chip-Seq_HEK293_Human | 2.00834667 |
| 18 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.00378101 |
| 19 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.00303192 |
| 20 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.92424859 |
| 21 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.77877815 |
| 22 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.70719192 |
| 23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.70589234 |
| 24 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.68237073 |
| 25 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.68077665 |
| 26 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.67706959 |
| 27 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.67528605 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.62445994 |
| 29 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.60117469 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60100730 |
| 31 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.58454526 |
| 32 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.50476673 |
| 33 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.46334554 |
| 34 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.43886276 |
| 35 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.43513049 |
| 36 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.42973004 |
| 37 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.42296299 |
| 38 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.42069767 |
| 39 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.40744918 |
| 40 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.40744918 |
| 41 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.38698510 |
| 42 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.37769135 |
| 43 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.37183137 |
| 44 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36666445 |
| 45 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.35285501 |
| 46 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34914028 |
| 47 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.34406960 |
| 48 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.33141178 |
| 49 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.32925676 |
| 50 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.32820047 |
| 51 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.32791928 |
| 52 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.31984284 |
| 53 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.31256647 |
| 54 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.30216733 |
| 55 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.30216733 |
| 56 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.27003269 |
| 57 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.26890667 |
| 58 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26306264 |
| 59 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.26127977 |
| 60 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26106215 |
| 61 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.25634141 |
| 62 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.25357537 |
| 63 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.23085929 |
| 64 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22473932 |
| 65 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.21710056 |
| 66 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.20734640 |
| 67 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.20057024 |
| 68 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.18788113 |
| 69 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.18701866 |
| 70 | NCOR_22424771_ChIP-Seq_293T_Human | 1.18602228 |
| 71 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.18124518 |
| 72 | GATA1_22025678_ChIP-Seq_K562_Human | 1.17366948 |
| 73 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15489071 |
| 74 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.14832636 |
| 75 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.13813708 |
| 76 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.13684678 |
| 77 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12882567 |
| 78 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.09432496 |
| 79 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09300693 |
| 80 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08940752 |
| 81 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.08908481 |
| 82 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.07802573 |
| 83 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.07370620 |
| 84 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.07110585 |
| 85 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05638459 |
| 86 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.05349436 |
| 87 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.05114269 |
| 88 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.04760868 |
| 89 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.04043972 |
| 90 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02252655 |
| 91 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.01849530 |
| 92 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.01054891 |
| 93 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.00498176 |
| 94 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.99538284 |
| 95 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97681618 |
| 96 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97484929 |
| 97 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96864456 |
| 98 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96666370 |
| 99 | JUN_21703547_ChIP-Seq_K562_Human | 0.96287259 |
| 100 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.95568126 |
| 101 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.93641862 |
| 102 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.91853788 |
| 103 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85693206 |
| 104 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.85620759 |
| 105 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.85176600 |
| 106 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84213230 |
| 107 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.83996485 |
| 108 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83019062 |
| 109 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83019062 |
| 110 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.82856127 |
| 111 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.82835505 |
| 112 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82682153 |
| 113 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.81605785 |
| 114 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81004656 |
| 115 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.79839150 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.79155361 |
| 117 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78603573 |
| 118 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.77119153 |
| 119 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.74206065 |
| 120 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.73025047 |
| 121 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.72065108 |
| 122 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.70983607 |
| 123 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.70074981 |
| 124 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.69978413 |
| 125 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.69246771 |
| 126 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.67649945 |
| 127 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.67270554 |
| 128 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.67040706 |
| 129 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.67026863 |
| 130 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.67016448 |
| 131 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.67016448 |
| 132 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.66461342 |
| 133 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.65278101 |
| 134 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.65278101 |
| 135 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.64552539 |
| 136 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.64307168 |
| 137 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.63968072 |
| 138 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.62965586 |
| 139 | AR_25329375_ChIP-Seq_VCAP_Human | 0.62733230 |
| 140 | CBP_21632823_ChIP-Seq_H3396_Human | 0.62511234 |
| 141 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.62308862 |
| 142 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.62074421 |
| 143 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.62021725 |
| 144 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.60236396 |
| 145 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.60144705 |
| 146 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.59195627 |
| 147 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.59179654 |
| 148 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.59177852 |
| 149 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.59096820 |
| 150 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.59078943 |
| 151 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.58544076 |
| 152 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.58521991 |
| 153 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.57708793 |
| 154 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.57646571 |
| 155 | * AR_19668381_ChIP-Seq_PC3_Human | 0.57527811 |
| 156 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.57012979 |
| 157 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.56984099 |
| 158 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.55674272 |
| 159 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.55528943 |
| 160 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.55417140 |
| 161 | AR_20517297_ChIP-Seq_VCAP_Human | 0.55096716 |
| 162 | KDM2B_26808549_Chip-Seq_REH_Human | 0.55064139 |
| 163 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.54562833 |
| 164 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.54483012 |
| 165 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.54331793 |
| 166 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.54130393 |
| 167 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.53994917 |
| 168 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.53994917 |
| 169 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.53805074 |
| 170 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53693946 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.04511270 |
| 2 | MP0005360_urolithiasis | 7.08750024 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.31291487 |
| 4 | MP0005365_abnormal_bile_salt | 6.07425409 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.90909071 |
| 6 | MP0003252_abnormal_bile_duct | 3.80905417 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.51304538 |
| 8 | MP0008877_abnormal_DNA_methylation | 3.45191395 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.44060883 |
| 10 | MP0003136_yellow_coat_color | 2.86831166 |
| 11 | MP0005083_abnormal_biliary_tract | 2.81246500 |
| 12 | MP0005332_abnormal_amino_acid | 2.74482190 |
| 13 | MP0003195_calcinosis | 2.70877463 |
| 14 | MP0009840_abnormal_foam_cell | 2.70679557 |
| 15 | MP0003787_abnormal_imprinting | 2.64335567 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.61423198 |
| 17 | MP0001986_abnormal_taste_sensitivity | 2.31758863 |
| 18 | MP0003011_delayed_dark_adaptation | 2.25155271 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.21989047 |
| 20 | MP0002102_abnormal_ear_morphology | 2.10422211 |
| 21 | MP0003880_abnormal_central_pattern | 2.10273763 |
| 22 | MP0001529_abnormal_vocalization | 2.07677363 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 2.06484665 |
| 24 | MP0003868_abnormal_feces_composition | 2.06362324 |
| 25 | MP0009046_muscle_twitch | 1.99818953 |
| 26 | MP0000609_abnormal_liver_physiology | 1.97672742 |
| 27 | MP0000372_irregular_coat_pigmentation | 1.93025095 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 1.87891021 |
| 29 | MP0003890_abnormal_embryonic-extraembry | 1.83666264 |
| 30 | MP0003646_muscle_fatigue | 1.83599835 |
| 31 | MP0005551_abnormal_eye_electrophysiolog | 1.82668343 |
| 32 | MP0005645_abnormal_hypothalamus_physiol | 1.81163587 |
| 33 | MP0003718_maternal_effect | 1.76320605 |
| 34 | MP0004142_abnormal_muscle_tone | 1.74253331 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.72507606 |
| 36 | MP0001764_abnormal_homeostasis | 1.71950335 |
| 37 | MP0001968_abnormal_touch/_nociception | 1.71268189 |
| 38 | MP0002272_abnormal_nervous_system | 1.70417241 |
| 39 | MP0005410_abnormal_fertilization | 1.69517721 |
| 40 | MP0002653_abnormal_ependyma_morphology | 1.68711626 |
| 41 | MP0005319_abnormal_enzyme/_coenzyme | 1.65966030 |
| 42 | MP0001486_abnormal_startle_reflex | 1.64287800 |
| 43 | MP0004147_increased_porphyrin_level | 1.61394538 |
| 44 | MP0001485_abnormal_pinna_reflex | 1.57934071 |
| 45 | MP0002638_abnormal_pupillary_reflex | 1.57461365 |
| 46 | MP0002735_abnormal_chemical_nociception | 1.56050226 |
| 47 | MP0003121_genomic_imprinting | 1.55337120 |
| 48 | MP0004133_heterotaxia | 1.52151585 |
| 49 | MP0006292_abnormal_olfactory_placode | 1.51735885 |
| 50 | MP0003122_maternal_imprinting | 1.47895309 |
| 51 | MP0005075_abnormal_melanosome_morpholog | 1.45449082 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.39221159 |
| 53 | MP0003878_abnormal_ear_physiology | 1.38330146 |
| 54 | MP0005377_hearing/vestibular/ear_phenot | 1.38330146 |
| 55 | MP0000631_abnormal_neuroendocrine_gland | 1.38029709 |
| 56 | MP0000569_abnormal_digit_pigmentation | 1.36655666 |
| 57 | MP0002876_abnormal_thyroid_physiology | 1.36081062 |
| 58 | MP0000427_abnormal_hair_cycle | 1.34294400 |
| 59 | MP0005379_endocrine/exocrine_gland_phen | 1.30782991 |
| 60 | MP0002572_abnormal_emotion/affect_behav | 1.30451379 |
| 61 | MP0009697_abnormal_copulation | 1.29443415 |
| 62 | MP0002736_abnormal_nociception_after | 1.28373261 |
| 63 | MP0002938_white_spotting | 1.28225673 |
| 64 | MP0002090_abnormal_vision | 1.24711151 |
| 65 | MP0002064_seizures | 1.24004235 |
| 66 | MP0001970_abnormal_pain_threshold | 1.23867277 |
| 67 | MP0002557_abnormal_social/conspecific_i | 1.22625935 |
| 68 | MP0005451_abnormal_body_composition | 1.20607584 |
| 69 | MP0002822_catalepsy | 1.19584682 |
| 70 | MP0002734_abnormal_mechanical_nocicepti | 1.17438772 |
| 71 | MP0002733_abnormal_thermal_nociception | 1.16384416 |
| 72 | MP0003635_abnormal_synaptic_transmissio | 1.16238876 |
| 73 | MP0002067_abnormal_sensory_capabilities | 1.16234939 |
| 74 | MP0004924_abnormal_behavior | 1.15368639 |
| 75 | MP0005386_behavior/neurological_phenoty | 1.15368639 |
| 76 | MP0002132_abnormal_respiratory_system | 1.10081453 |
| 77 | MP0005647_abnormal_sex_gland | 1.09658747 |
| 78 | MP0009643_abnormal_urine_homeostasis | 1.08888394 |
| 79 | MP0001188_hyperpigmentation | 1.03199037 |
| 80 | MP0004742_abnormal_vestibular_system | 1.01925262 |
| 81 | MP0002063_abnormal_learning/memory/cond | 0.99776295 |
| 82 | MP0000604_amyloidosis | 0.99706967 |
| 83 | MP0003698_abnormal_male_reproductive | 0.99510848 |
| 84 | MP0004885_abnormal_endolymph | 0.99360840 |
| 85 | MP0004270_analgesia | 0.97359848 |
| 86 | MP0005167_abnormal_blood-brain_barrier | 0.96738443 |
| 87 | MP0008995_early_reproductive_senescence | 0.95610825 |
| 88 | MP0002078_abnormal_glucose_homeostasis | 0.94566993 |
| 89 | MP0005084_abnormal_gallbladder_morpholo | 0.94151681 |
| 90 | MP0003137_abnormal_impulse_conducting | 0.94095386 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 0.94011229 |
| 92 | MP0005670_abnormal_white_adipose | 0.92698791 |
| 93 | MP0000598_abnormal_liver_morphology | 0.92080945 |
| 94 | MP0010368_abnormal_lymphatic_system | 0.91956825 |
| 95 | MP0005423_abnormal_somatic_nervous | 0.90764085 |
| 96 | MP0003119_abnormal_digestive_system | 0.90214005 |
| 97 | MP0009764_decreased_sensitivity_to | 0.89766637 |
| 98 | MP0004085_abnormal_heartbeat | 0.89352832 |
| 99 | MP0001929_abnormal_gametogenesis | 0.89350383 |
| 100 | MP0005535_abnormal_body_temperature | 0.89237102 |
| 101 | MP0005636_abnormal_mineral_homeostasis | 0.88184407 |
| 102 | MP0001963_abnormal_hearing_physiology | 0.87668392 |
| 103 | MP0000516_abnormal_urinary_system | 0.87244386 |
| 104 | MP0005367_renal/urinary_system_phenotyp | 0.87244386 |
| 105 | MP0008058_abnormal_DNA_repair | 0.86196827 |
| 106 | MP0002254_reproductive_system_inflammat | 0.86191050 |
| 107 | MP0003690_abnormal_glial_cell | 0.85802307 |
| 108 | MP0002095_abnormal_skin_pigmentation | 0.85272616 |
| 109 | MP0003567_abnormal_fetal_cardiomyocyte | 0.83669060 |
| 110 | MP0004130_abnormal_muscle_cell | 0.83018172 |
| 111 | MP0006082_CNS_inflammation | 0.82974580 |
| 112 | MP0009642_abnormal_blood_homeostasis | 0.82200780 |
| 113 | MP0002210_abnormal_sex_determination | 0.82185258 |
| 114 | MP0003329_amyloid_beta_deposits | 0.81705606 |
| 115 | MP0005174_abnormal_tail_pigmentation | 0.79833063 |
| 116 | MP0005334_abnormal_fat_pad | 0.79813671 |
| 117 | MP0002184_abnormal_innervation | 0.79719728 |
| 118 | MP0002160_abnormal_reproductive_system | 0.79417791 |
| 119 | MP0002163_abnormal_gland_morphology | 0.79053060 |
| 120 | MP0002751_abnormal_autonomic_nervous | 0.78366501 |
| 121 | MP0005389_reproductive_system_phenotype | 0.78341035 |
| 122 | MP0009763_increased_sensitivity_to | 0.77791841 |
| 123 | MP0001905_abnormal_dopamine_level | 0.77322441 |
| 124 | MP0001919_abnormal_reproductive_system | 0.77103714 |
| 125 | MP0005376_homeostasis/metabolism_phenot | 0.75952362 |
| 126 | MP0002971_abnormal_brown_adipose | 0.75312833 |
| 127 | MP0001756_abnormal_urination | 0.75223114 |
| 128 | MP0005253_abnormal_eye_physiology | 0.73858752 |
| 129 | MP0001661_extended_life_span | 0.73353962 |
| 130 | MP0005220_abnormal_exocrine_pancreas | 0.71184441 |
| 131 | MP0003705_abnormal_hypodermis_morpholog | 0.70577876 |
| 132 | MP0002837_dystrophic_cardiac_calcinosis | 0.70464364 |
| 133 | MP0005448_abnormal_energy_balance | 0.69897838 |
| 134 | MP0002909_abnormal_adrenal_gland | 0.69878117 |
| 135 | MP0001324_abnormal_eye_pigmentation | 0.68834630 |
| 136 | MP0000639_abnormal_adrenal_gland | 0.66824127 |
| 137 | MP0006036_abnormal_mitochondrial_physio | 0.65333633 |
| 138 | MP0001502_abnormal_circadian_rhythm | 0.64135899 |
| 139 | MP0006035_abnormal_mitochondrial_morpho | 0.61427591 |
| 140 | MP0003186_abnormal_redox_activity | 0.61012279 |
| 141 | MP0008469_abnormal_protein_level | 0.60823605 |
| 142 | MP0005195_abnormal_posterior_eye | 0.60531180 |
| 143 | MP0009765_abnormal_xenobiotic_induced | 0.60327253 |
| 144 | MP0005266_abnormal_metabolism | 0.59607772 |
| 145 | MP0002229_neurodegeneration | 0.58484972 |
| 146 | MP0008874_decreased_physiological_sensi | 0.58169326 |
| 147 | MP0004859_abnormal_synaptic_plasticity | 0.57255136 |
| 148 | MP0009384_cardiac_valve_regurgitation | 0.57040892 |
| 149 | MP0000230_abnormal_systemic_arterial | 0.55128962 |
| 150 | MP0003953_abnormal_hormone_level | 0.54714419 |
| 151 | MP0005595_abnormal_vascular_smooth | 0.53844943 |
| 152 | MP0002928_abnormal_bile_duct | 0.53126254 |
| 153 | MP0008872_abnormal_physiological_respon | 0.50976833 |
| 154 | MP0005408_hypopigmentation | 0.48720279 |
| 155 | MP0003075_altered_response_to | 0.48138654 |
| 156 | MP0004043_abnormal_pH_regulation | 0.45713355 |
| 157 | MP0003633_abnormal_nervous_system | 0.45613079 |
| 158 | MP0004782_abnormal_surfactant_physiolog | 0.43948332 |
| 159 | MP0005646_abnormal_pituitary_gland | 0.43269553 |
| 160 | MP0005248_abnormal_Harderian_gland | 0.41501213 |
| 161 | MP0009745_abnormal_behavioral_response | 0.40889495 |
| 162 | MP0005395_other_phenotype | 0.39840270 |
| 163 | MP0001944_abnormal_pancreas_morphology | 0.39761374 |
| 164 | MP0001501_abnormal_sleep_pattern | 0.39478194 |
| 165 | MP0005187_abnormal_penis_morphology | 0.38807775 |
| 166 | MP0003632_abnormal_nervous_system | 0.38433047 |
| 167 | MP0002069_abnormal_eating/drinking_beha | 0.36812881 |
| 168 | MP0006072_abnormal_retinal_apoptosis | 0.36754656 |
| 169 | MP0010386_abnormal_urinary_bladder | 0.36251562 |
| 170 | MP0000579_abnormal_nail_morphology | 0.36238618 |
| 171 | MP0005666_abnormal_adipose_tissue | 0.36167329 |
| 172 | MP0003631_nervous_system_phenotype | 0.35940916 |
| 173 | MP0001984_abnormal_olfaction | 0.34445170 |
| 174 | MP0003638_abnormal_response/metabolism_ | 0.34375119 |
| 175 | MP0002136_abnormal_kidney_physiology | 0.33727912 |
| 176 | MP0006276_abnormal_autonomic_nervous | 0.33607959 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.09393695 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.00580579 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.00065975 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.19614370 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.16210886 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.79652931 |
| 7 | Xanthomatosis (HP:0000991) | 5.75159793 |
| 8 | Complement deficiency (HP:0004431) | 5.40830858 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.18273017 |
| 10 | Hyperglycinemia (HP:0002154) | 4.75682989 |
| 11 | Joint hemorrhage (HP:0005261) | 4.39966434 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.33839740 |
| 13 | Ketosis (HP:0001946) | 4.29393020 |
| 14 | Hyperammonemia (HP:0001987) | 4.24832570 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.20132746 |
| 16 | Epidermoid cyst (HP:0200040) | 4.18249600 |
| 17 | Conjugated hyperbilirubinemia (HP:0002908) | 4.03877635 |
| 18 | Pancreatic cysts (HP:0001737) | 4.00162406 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.90679177 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 3.85964762 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.85638176 |
| 22 | Fat malabsorption (HP:0002630) | 3.84525736 |
| 23 | Hypoglycemic coma (HP:0001325) | 3.83573481 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.83343908 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.83343908 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.83115132 |
| 27 | Hyperglycinuria (HP:0003108) | 3.82383458 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.81331914 |
| 29 | Abnormality of complement system (HP:0005339) | 3.77952466 |
| 30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.70866721 |
| 31 | Abnormality of midbrain morphology (HP:0002418) | 3.67972996 |
| 32 | Molar tooth sign on MRI (HP:0002419) | 3.67972996 |
| 33 | Pancreatic fibrosis (HP:0100732) | 3.66917801 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.49022914 |
| 35 | Chronic hepatic failure (HP:0100626) | 3.39650108 |
| 36 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.26804304 |
| 37 | True hermaphroditism (HP:0010459) | 3.22065467 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.21684419 |
| 39 | Congenital stationary night blindness (HP:0007642) | 3.20406321 |
| 40 | Ketoacidosis (HP:0001993) | 3.16278728 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.10270340 |
| 42 | Focal motor seizures (HP:0011153) | 3.07670018 |
| 43 | Inability to walk (HP:0002540) | 3.05699398 |
| 44 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.03986243 |
| 45 | Hyperbilirubinemia (HP:0002904) | 3.02574117 |
| 46 | Spontaneous abortion (HP:0005268) | 3.00691240 |
| 47 | Nephronophthisis (HP:0000090) | 2.98820103 |
| 48 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.96150045 |
| 49 | Abnormal gallbladder physiology (HP:0012438) | 2.91280803 |
| 50 | Cholecystitis (HP:0001082) | 2.91280803 |
| 51 | Delayed CNS myelination (HP:0002188) | 2.89981818 |
| 52 | Skin nodule (HP:0200036) | 2.87240628 |
| 53 | Vascular calcification (HP:0004934) | 2.84888225 |
| 54 | Abnormality of the labia minora (HP:0012880) | 2.83519794 |
| 55 | Hypoglycemic seizures (HP:0002173) | 2.78168475 |
| 56 | Gaze-evoked nystagmus (HP:0000640) | 2.76757628 |
| 57 | Abnormality of the renal cortex (HP:0011035) | 2.74058556 |
| 58 | Hepatocellular carcinoma (HP:0001402) | 2.74004467 |
| 59 | Steatorrhea (HP:0002570) | 2.72726067 |
| 60 | Abnormality of nucleobase metabolism (HP:0010932) | 2.71417553 |
| 61 | Intestinal atresia (HP:0011100) | 2.70609348 |
| 62 | Chorioretinal atrophy (HP:0000533) | 2.66539081 |
| 63 | Hypochromic microcytic anemia (HP:0004840) | 2.66086958 |
| 64 | Pigmentary retinal degeneration (HP:0001146) | 2.65998212 |
| 65 | Abnormality of the renal medulla (HP:0100957) | 2.65727839 |
| 66 | Sensorimotor neuropathy (HP:0007141) | 2.64221013 |
| 67 | Attenuation of retinal blood vessels (HP:0007843) | 2.63478407 |
| 68 | Focal seizures (HP:0007359) | 2.61387126 |
| 69 | Metabolic acidosis (HP:0001942) | 2.61134545 |
| 70 | Progressive inability to walk (HP:0002505) | 2.60401636 |
| 71 | Broad-based gait (HP:0002136) | 2.59287521 |
| 72 | 3-Methylglutaconic aciduria (HP:0003535) | 2.57599451 |
| 73 | Myocardial infarction (HP:0001658) | 2.57287634 |
| 74 | Pendular nystagmus (HP:0012043) | 2.54157274 |
| 75 | Cardiovascular calcification (HP:0011915) | 2.52646716 |
| 76 | Mitral stenosis (HP:0001718) | 2.51727227 |
| 77 | Cystic liver disease (HP:0006706) | 2.51350912 |
| 78 | Methylmalonic acidemia (HP:0002912) | 2.50737693 |
| 79 | Abnormal gallbladder morphology (HP:0012437) | 2.50420958 |
| 80 | Atonic seizures (HP:0010819) | 2.50341603 |
| 81 | Type II lissencephaly (HP:0007260) | 2.49238516 |
| 82 | Systemic lupus erythematosus (HP:0002725) | 2.48963166 |
| 83 | Agitation (HP:0000713) | 2.47606983 |
| 84 | Abolished electroretinogram (ERG) (HP:0000550) | 2.44506371 |
| 85 | Dialeptic seizures (HP:0011146) | 2.44410368 |
| 86 | Abnormality of purine metabolism (HP:0004352) | 2.43724177 |
| 87 | Gout (HP:0001997) | 2.41924864 |
| 88 | Medial flaring of the eyebrow (HP:0010747) | 2.40955637 |
| 89 | Cholelithiasis (HP:0001081) | 2.40680710 |
| 90 | Malnutrition (HP:0004395) | 2.39608151 |
| 91 | Hypothermia (HP:0002045) | 2.36543077 |
| 92 | Hypsarrhythmia (HP:0002521) | 2.34938026 |
| 93 | Neonatal onset (HP:0003623) | 2.34670118 |
| 94 | Febrile seizures (HP:0002373) | 2.33079510 |
| 95 | Lethargy (HP:0001254) | 2.31925532 |
| 96 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.31009392 |
| 97 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.30211001 |
| 98 | Dicarboxylic aciduria (HP:0003215) | 2.30211001 |
| 99 | Lissencephaly (HP:0001339) | 2.30162478 |
| 100 | Limb dystonia (HP:0002451) | 2.29846792 |
| 101 | Abnormal drinking behavior (HP:0030082) | 2.28927296 |
| 102 | Polydipsia (HP:0001959) | 2.28927296 |
| 103 | EEG with generalized epileptiform discharges (HP:0011198) | 2.27272510 |
| 104 | Genetic anticipation (HP:0003743) | 2.22392374 |
| 105 | Sclerocornea (HP:0000647) | 2.21577318 |
| 106 | Acanthocytosis (HP:0001927) | 2.21365812 |
| 107 | Late onset (HP:0003584) | 2.20188550 |
| 108 | Irritability (HP:0000737) | 2.19893915 |
| 109 | Hypoplasia of the fovea (HP:0007750) | 2.19736501 |
| 110 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.19736501 |
| 111 | Epileptiform EEG discharges (HP:0011182) | 2.19703146 |
| 112 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.17810752 |
| 113 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.17054764 |
| 114 | Glomerulonephritis (HP:0000099) | 2.16532010 |
| 115 | Acute necrotizing encephalopathy (HP:0006965) | 2.15442597 |
| 116 | Fair hair (HP:0002286) | 2.11708996 |
| 117 | Enlarged kidneys (HP:0000105) | 2.11507642 |
| 118 | Spastic diplegia (HP:0001264) | 2.11441388 |
| 119 | Abnormality of the gallbladder (HP:0005264) | 2.11405668 |
| 120 | Brushfield spots (HP:0001088) | 2.11119731 |
| 121 | Status epilepticus (HP:0002133) | 2.09878865 |
| 122 | Increased CSF lactate (HP:0002490) | 2.07680553 |
| 123 | Amyloidosis (HP:0011034) | 2.07627087 |
| 124 | Polyuria (HP:0000103) | 2.07528980 |
| 125 | Progressive macrocephaly (HP:0004481) | 2.05578855 |
| 126 | Hemiparesis (HP:0001269) | 2.05499166 |
| 127 | Methylmalonic aciduria (HP:0012120) | 2.04604681 |
| 128 | Mitochondrial inheritance (HP:0001427) | 2.02994837 |
| 129 | Progressive cerebellar ataxia (HP:0002073) | 2.02391297 |
| 130 | Absence seizures (HP:0002121) | 2.01910327 |
| 131 | Tubular atrophy (HP:0000092) | 2.01707925 |
| 132 | Polyphagia (HP:0002591) | 1.95995975 |
| 133 | Anencephaly (HP:0002323) | 1.95639223 |
| 134 | Pancreatitis (HP:0001733) | 1.94995535 |
| 135 | Symptomatic seizures (HP:0011145) | 1.94273596 |
| 136 | Hyperglycemia (HP:0003074) | 1.93940381 |
| 137 | Acute encephalopathy (HP:0006846) | 1.93844011 |
| 138 | Cerebral edema (HP:0002181) | 1.91952583 |
| 139 | Renal cortical cysts (HP:0000803) | 1.91496861 |
| 140 | Vomiting (HP:0002013) | 1.90931216 |
| 141 | Large for gestational age (HP:0001520) | 1.89984351 |
| 142 | Thyroid-stimulating hormone excess (HP:0002925) | 1.89546076 |
| 143 | Male pseudohermaphroditism (HP:0000037) | 1.89219426 |
| 144 | Central scotoma (HP:0000603) | 1.88129105 |
| 145 | Abnormality of vitamin metabolism (HP:0100508) | 1.88124015 |
| 146 | Decreased central vision (HP:0007663) | 1.88122800 |
| 147 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.85674978 |
| 148 | Optic disc pallor (HP:0000543) | 1.85628526 |
| 149 | Menorrhagia (HP:0000132) | 1.85131582 |
| 150 | Pachygyria (HP:0001302) | 1.84793090 |
| 151 | Hyperventilation (HP:0002883) | 1.84208390 |
| 152 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.84164030 |
| 153 | Optic nerve hypoplasia (HP:0000609) | 1.83864769 |
| 154 | Congenital, generalized hypertrichosis (HP:0004540) | 1.83588526 |
| 155 | Gait imbalance (HP:0002141) | 1.83055365 |
| 156 | Hypomagnesemia (HP:0002917) | 1.82238629 |
| 157 | Gastrointestinal atresia (HP:0002589) | 1.80587295 |
| 158 | Hepatocellular necrosis (HP:0001404) | 1.80185136 |
| 159 | Tubulointerstitial nephritis (HP:0001970) | 1.79783158 |
| 160 | Absent speech (HP:0001344) | 1.79089664 |
| 161 | Abnormality of vitamin B metabolism (HP:0004340) | 1.79059888 |
| 162 | Acute hepatic failure (HP:0006554) | 1.78962012 |
| 163 | Nephritis (HP:0000123) | 1.78684562 |
| 164 | Amelogenesis imperfecta (HP:0000705) | 1.78362643 |
| 165 | Increased corneal curvature (HP:0100692) | 1.76444233 |
| 166 | Keratoconus (HP:0000563) | 1.76444233 |
| 167 | Poikilocytosis (HP:0004447) | 1.74969235 |
| 168 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.74959077 |
| 169 | Gingival bleeding (HP:0000225) | 1.74689924 |
| 170 | Elevated hepatic transaminases (HP:0002910) | 1.74666412 |
| 171 | Retinal dysplasia (HP:0007973) | 1.74570801 |
| 172 | Tachypnea (HP:0002789) | 1.73595380 |
| 173 | Genital tract atresia (HP:0001827) | 1.73240336 |
| 174 | Protruding tongue (HP:0010808) | 1.73201635 |
| 175 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.72805964 |
| 176 | Opisthotonus (HP:0002179) | 1.72684062 |
| 177 | Bile duct proliferation (HP:0001408) | 1.72536677 |
| 178 | Abnormal biliary tract physiology (HP:0012439) | 1.72536677 |
| 179 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.71581613 |
| 180 | Abnormality of the fovea (HP:0000493) | 1.71406058 |
| 181 | Hepatic necrosis (HP:0002605) | 1.71222058 |
| 182 | Abnormality of proline metabolism (HP:0010907) | 1.71111761 |
| 183 | Hydroxyprolinuria (HP:0003080) | 1.71111761 |
| 184 | Occipital encephalocele (HP:0002085) | 1.70246830 |
| 185 | Retinal atrophy (HP:0001105) | 1.69830468 |
| 186 | Congenital primary aphakia (HP:0007707) | 1.69823117 |
| 187 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.69371511 |
| 188 | Congenital sensorineural hearing impairment (HP:0008527) | 1.68767640 |
| 189 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.68564931 |
| 190 | Drooling (HP:0002307) | 1.67736136 |
| 191 | Colon cancer (HP:0003003) | 1.66814816 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.49436644 |
| 2 | INSRR | 3.78282879 |
| 3 | EPHA3 | 3.27234982 |
| 4 | BMPR1B | 3.10346002 |
| 5 | ERN1 | 3.09647115 |
| 6 | SIK1 | 3.08414993 |
| 7 | FGFR4 | 2.95607754 |
| 8 | MAP4K2 | 2.82071921 |
| 9 | LATS1 | 2.79167363 |
| 10 | EPHA4 | 2.73096448 |
| 11 | TAOK3 | 2.62379597 |
| 12 | ERBB4 | 2.48227733 |
| 13 | TRIM28 | 2.33013181 |
| 14 | ZAK | 2.27815097 |
| 15 | MAPK15 | 2.15045354 |
| 16 | DAPK2 | 2.13472694 |
| 17 | MAP2K4 | 2.12568087 |
| 18 | ADRBK2 | 2.11228096 |
| 19 | PIK3CG | 2.08196692 |
| 20 | WNK4 | 2.04475779 |
| 21 | STK39 | 2.02966369 |
| 22 | PINK1 | 1.88006448 |
| 23 | MAP3K13 | 1.83793083 |
| 24 | OXSR1 | 1.81135306 |
| 25 | PRPF4B | 1.75893225 |
| 26 | ACVR1B | 1.71196073 |
| 27 | TNIK | 1.67448961 |
| 28 | MAPK13 | 1.62688881 |
| 29 | MKNK2 | 1.57173474 |
| 30 | TAOK2 | 1.50162925 |
| 31 | MST1R | 1.46352933 |
| 32 | STK16 | 1.40443752 |
| 33 | STK38L | 1.38823308 |
| 34 | GRK1 | 1.37613237 |
| 35 | EIF2AK3 | 1.35811461 |
| 36 | PRKCE | 1.27382974 |
| 37 | DYRK2 | 1.27053487 |
| 38 | PTK2B | 1.26787947 |
| 39 | CAMKK2 | 1.26681567 |
| 40 | MST4 | 1.25263344 |
| 41 | CASK | 1.24881819 |
| 42 | MAP2K7 | 1.23156284 |
| 43 | MAP3K7 | 1.21866315 |
| 44 | PRKAA2 | 1.21225464 |
| 45 | ABL2 | 1.20258282 |
| 46 | MAPK11 | 1.17766064 |
| 47 | KSR2 | 1.15958342 |
| 48 | MAPKAPK3 | 1.13798071 |
| 49 | ITK | 1.13749483 |
| 50 | BCR | 1.13672709 |
| 51 | PAK6 | 1.13499372 |
| 52 | PLK2 | 1.12949016 |
| 53 | BRD4 | 1.11901392 |
| 54 | PAK3 | 1.09788208 |
| 55 | MUSK | 1.06787961 |
| 56 | PRKCZ | 1.06251967 |
| 57 | PTK6 | 1.04739301 |
| 58 | CAMK2G | 1.04470450 |
| 59 | PRKAA1 | 1.02345690 |
| 60 | MYLK | 1.02011109 |
| 61 | FRK | 0.99972636 |
| 62 | ERBB2 | 0.97923106 |
| 63 | AKT3 | 0.97567983 |
| 64 | KSR1 | 0.97119761 |
| 65 | PKN2 | 0.95845695 |
| 66 | NME1 | 0.95247818 |
| 67 | CAMKK1 | 0.94415834 |
| 68 | MAP3K4 | 0.94144449 |
| 69 | MAPK12 | 0.91730957 |
| 70 | PRKD2 | 0.89810353 |
| 71 | STK38 | 0.87530384 |
| 72 | WNK3 | 0.87123623 |
| 73 | MAP3K9 | 0.83503845 |
| 74 | CSNK1A1L | 0.83314596 |
| 75 | SGK2 | 0.81042656 |
| 76 | MKNK1 | 0.80680252 |
| 77 | STK3 | 0.80508263 |
| 78 | PRKCG | 0.79627163 |
| 79 | ADRBK1 | 0.79341067 |
| 80 | PDGFRA | 0.78665074 |
| 81 | NLK | 0.77386944 |
| 82 | NUAK1 | 0.75819258 |
| 83 | PDPK1 | 0.72677426 |
| 84 | MAP3K12 | 0.72574657 |
| 85 | JAK2 | 0.72111988 |
| 86 | SGK223 | 0.71978988 |
| 87 | SGK494 | 0.71978988 |
| 88 | CAMK2A | 0.71906234 |
| 89 | PBK | 0.70131155 |
| 90 | RIPK1 | 0.68838294 |
| 91 | JAK1 | 0.68829512 |
| 92 | NTRK3 | 0.68694787 |
| 93 | SGK3 | 0.68662650 |
| 94 | PNCK | 0.68224287 |
| 95 | CAMK1D | 0.68154567 |
| 96 | PRKACG | 0.67553261 |
| 97 | MAPK4 | 0.66207743 |
| 98 | CSNK1A1 | 0.63241990 |
| 99 | CSNK1G2 | 0.63219888 |
| 100 | FLT3 | 0.62152956 |
| 101 | PDK2 | 0.61482409 |
| 102 | TAOK1 | 0.61325305 |
| 103 | ERBB3 | 0.61034066 |
| 104 | TGFBR1 | 0.59608678 |
| 105 | MAP3K1 | 0.58389440 |
| 106 | SIK3 | 0.57281339 |
| 107 | BRSK2 | 0.56354764 |
| 108 | PRKCI | 0.56062355 |
| 109 | TNK2 | 0.55633308 |
| 110 | CSNK1G1 | 0.55185808 |
| 111 | CAMK2B | 0.54314284 |
| 112 | DYRK3 | 0.54278109 |
| 113 | TIE1 | 0.54149287 |
| 114 | EPHB1 | 0.54001448 |
| 115 | MAPK7 | 0.53860215 |
| 116 | FGFR2 | 0.52685571 |
| 117 | PHKG1 | 0.52215877 |
| 118 | PHKG2 | 0.52215877 |
| 119 | PKN1 | 0.51884494 |
| 120 | MINK1 | 0.51630410 |
| 121 | PIK3CA | 0.50588580 |
| 122 | PRKACA | 0.49561730 |
| 123 | DAPK1 | 0.49536363 |
| 124 | MAP2K1 | 0.49443849 |
| 125 | PLK3 | 0.48732769 |
| 126 | CAMK4 | 0.48231788 |
| 127 | TEC | 0.46947968 |
| 128 | FER | 0.45567514 |
| 129 | LATS2 | 0.45479654 |
| 130 | TRIB3 | 0.45165677 |
| 131 | MARK1 | 0.45073603 |
| 132 | MAPKAPK5 | 0.44995337 |
| 133 | MAP3K6 | 0.44415302 |
| 134 | CAMK2D | 0.44068857 |
| 135 | TSSK6 | 0.43826562 |
| 136 | RPS6KA3 | 0.43766759 |
| 137 | GSK3A | 0.43563831 |
| 138 | IRAK2 | 0.43288693 |
| 139 | PRKG1 | 0.43063532 |
| 140 | PTK2 | 0.42782351 |
| 141 | CSNK1D | 0.41964902 |
| 142 | CAMK1 | 0.41659786 |
| 143 | PRKCH | 0.41478978 |
| 144 | PRKD1 | 0.41277323 |
| 145 | CAMK1G | 0.41018632 |
| 146 | VRK1 | 0.40781665 |
| 147 | PRKCQ | 0.40547363 |
| 148 | PRKCA | 0.40446320 |
| 149 | MAP3K2 | 0.40165066 |
| 150 | TYK2 | 0.40126765 |
| 151 | NEK9 | 0.38920004 |
| 152 | CSNK1G3 | 0.38210265 |
| 153 | MAP2K6 | 0.38090919 |
| 154 | STK11 | 0.37803862 |
| 155 | NTRK2 | 0.36408380 |
| 156 | TYRO3 | 0.34923342 |
| 157 | RPS6KA5 | 0.33847784 |
| 158 | PLK4 | 0.33383287 |
| 159 | PRKACB | 0.32838302 |
| 160 | TXK | 0.32562232 |
| 161 | TRPM7 | 0.31607169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.60520584 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.52921760 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.27682869 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.13760932 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.99759961 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68119617 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.65374932 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.60485904 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.59552255 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.53107741 |
| 11 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.47862991 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.36126426 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.33440655 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.30628981 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.28606520 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13617562 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.02761068 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.98261030 |
| 19 | Basal transcription factors_Homo sapiens_hsa03022 | 1.94034365 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.93116866 |
| 21 | RNA polymerase_Homo sapiens_hsa03020 | 1.86555926 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84671166 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.81540104 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.81282033 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.79943221 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.78449058 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.76659323 |
| 28 | Parkinsons disease_Homo sapiens_hsa05012 | 1.75399969 |
| 29 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.74918775 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.72439200 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.70751106 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.70616466 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.70170281 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.65206414 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64102398 |
| 36 | Taste transduction_Homo sapiens_hsa04742 | 1.62869635 |
| 37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.59572214 |
| 38 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.54952359 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.54162361 |
| 40 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.51104031 |
| 41 | RNA degradation_Homo sapiens_hsa03018 | 1.51053253 |
| 42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.49711031 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49462503 |
| 44 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.49175108 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.46578554 |
| 46 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.45404955 |
| 47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.42565060 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41756140 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.41252588 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.36723076 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.35094446 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.29696220 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.28607807 |
| 54 | Huntingtons disease_Homo sapiens_hsa05016 | 1.26255083 |
| 55 | Homologous recombination_Homo sapiens_hsa03440 | 1.25429106 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22691108 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22513745 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21283674 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.20652671 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.20041125 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.18990760 |
| 62 | Phototransduction_Homo sapiens_hsa04744 | 1.18953246 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11078815 |
| 64 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.08503141 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.06737773 |
| 66 | Carbon metabolism_Homo sapiens_hsa01200 | 1.03155996 |
| 67 | Alzheimers disease_Homo sapiens_hsa05010 | 1.02058478 |
| 68 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.00320796 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.98853795 |
| 70 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.95106523 |
| 71 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.94537248 |
| 72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90291235 |
| 73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.86468836 |
| 74 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.86422728 |
| 75 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.83807607 |
| 76 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.82832765 |
| 77 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.82369400 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 0.81876382 |
| 79 | Lysine degradation_Homo sapiens_hsa00310 | 0.80888346 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78359500 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.77772185 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75824688 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74758727 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72283202 |
| 85 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71345634 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69226270 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66986813 |
| 88 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.66703759 |
| 89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.64151000 |
| 90 | Sulfur relay system_Homo sapiens_hsa04122 | 0.63120780 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62748192 |
| 92 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.58169740 |
| 93 | RNA transport_Homo sapiens_hsa03013 | 0.57585111 |
| 94 | Proteasome_Homo sapiens_hsa03050 | 0.56470462 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.55430585 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.54862699 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.50862250 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50543136 |
| 99 | Salivary secretion_Homo sapiens_hsa04970 | 0.50312293 |
| 100 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.46721991 |
| 101 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45408416 |
| 102 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.42927931 |
| 103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.42853522 |
| 104 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39021468 |
| 105 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38068293 |
| 106 | GABAergic synapse_Homo sapiens_hsa04727 | 0.37009751 |
| 107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36045011 |
| 108 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.35163787 |
| 109 | Circadian rhythm_Homo sapiens_hsa04710 | 0.35152881 |
| 110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34700592 |
| 111 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.34571056 |
| 112 | Long-term depression_Homo sapiens_hsa04730 | 0.33328502 |
| 113 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.33323956 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29965401 |
| 115 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.29532558 |
| 116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28727966 |
| 117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27865028 |
| 118 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.27781173 |
| 119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27126135 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.23748593 |
| 121 | Nicotine addiction_Homo sapiens_hsa05033 | 0.21105024 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19664537 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18492107 |
| 124 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.14947924 |
| 125 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.11724809 |
| 126 | Insulin secretion_Homo sapiens_hsa04911 | 0.09782254 |
| 127 | Morphine addiction_Homo sapiens_hsa05032 | 0.09338733 |
| 128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06300535 |
| 129 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.06175755 |
| 130 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.02704126 |
| 131 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.02067994 |
| 132 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.01841823 |
| 133 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.00319589 |
| 134 | Renin secretion_Homo sapiens_hsa04924 | 0.00051631 |
| 135 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0852398 |
| 136 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0390371 |
| 137 | Circadian entrainment_Homo sapiens_hsa04713 | -0.0357157 |
| 138 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | -0.0255178 |
| 139 | Olfactory transduction_Homo sapiens_hsa04740 | -0.0071989 |
| 140 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0063181 |

